He M, Jiang YZ, Gong Y, Fan L, et al. Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial. BMJ 2024;387:e079603.
PMID: 39442958